S1, Ep. 1: The Boogeyman In The Tax Code

The debate regarding whether incarcerated people who perform work are employees and thus entitled to federal wage and hour protections is set to continue to develop. 

The U.S. Department of Labor's proposed rule to end employers' ability to pay workers with disabilities less than the federal minimum wage comes as time is running out to end the long-standing but controversial program before Republicans take back the White House and Congress. He ... Show More

When it comes to artificial intelligence, most early adopters fear the so-called hallucinations that the systems can produce. But one scholar says the creativity those hallucinations represent is actually a valuable feature lawyers should embrace. At the 25th annual Burton Awards ... Show More

In a major shift that would modify laws set half a decade ago, states and cities around the United States are moving to legalize psychedelics for use as a medical treatment.The sudden change of heart has a lot to do with who is asking for the substances.Guest: Andrew Jacobs, a he ... Show More

Psychedelic drugs have been illegal for 50 years, but they’re trickling back into the mainstream because they show promise in helping treat post-traumatic stress disorder and other mental health challenges. We begin the hour with reporter Jonathan A. Davis visiting Psychedelic Sc ... Show More

Bad trips, anti-drug PSAs, and the crackdown under the Controlled Substances Act of 1970 helped stigmatize psychedelics in the U.S. But now, there’s renewed clinical inquiry into whether these drugs can ease emotional trauma. To understand the future of psychedelics, Audie calls ... Show More

Psychedelic drugs—such as LSD and psilocybin, the psychoactive compound found in magic mushrooms—may be coming to the medicine cabinet. Research into their use to treat mental-health conditions was long blocked by law and stigma. But in recent years, there has been a revival of i ... Show More

Psychedelic drugs—such as LSD and psilocybin, the psychoactive compound found in magic mushrooms—may be coming to the medicine cabinet. Research into their use to treat mental-health conditions was long blocked by law and stigma. But in recent years, there has been a revival of i ... Show More

This week in the U.S. Electoral vote, in Washington, D.C., and Oregon, voters chose to get on the path to decriminalize psilocybin for therapeutic use. This past August in Canada, four terminally ill cancer patients were given approval to use psilocybin as part of their end of li ... Show More

Judith Warner speaks with Dr. Matthew Johnson about the state of psychedelic research today and the likelihood that certain drugs — MDMA and psilocybin specifically — could soon be approved for the treatment of conditions like addiction and PTSD. Psychedelics have long been known ... Show More

Derek investigates a recent NY Times essay by Michael Pollan as an entry point to discuss big questions in psychedelics and conspirituality: How do we honor indigenous traditions as psychedelics are legalized (and monetized)? What dangers lie ahead as pharmaceutical companies and ... Show More

This episode is brought to you by Rupa Health, Cozy Earth, Beekeeper’s Naturals, and Levels. We’re in the midst of a psychedelic renaissance. Compounds that have long been considered recreational drugs by conventional standards are finally being recognized through science as powe ... Show More

Voters in Oregon have approved a law allowing people to take psilocybin, the psychedelic substance in magic mushrooms. Users will be able to apply to go to a licensed facility and take the drug with the help of a trained supervisor. The evidence suggests that this could successfu ... Show More